Stay updated on CD123xCD3 DuoBody Dose Escalation Clinical Trial
Sign up to get notified when there's something new on the CD123xCD3 DuoBody Dose Escalation Clinical Trial page.

Latest updates to the CD123xCD3 DuoBody Dose Escalation Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference5%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference5%
- Check39 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.3%
- Check54 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.3%
- Check61 days agoChange DetectedThe website has updated the 'type of intervention' feature from version 2.13.3 to 2.14.0, indicating a significant revision.SummaryDifference1.0%
- Check90 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.3%
Stay in the know with updates to CD123xCD3 DuoBody Dose Escalation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CD123xCD3 DuoBody Dose Escalation Clinical Trial page.